ISRCTN79841039Completed未知
Assessing the effects of supplementation with Nutrof® Total on macular pigment optical density
Spectrum Thea Pharmaceuticals (UK)0 sites32 target enrollmentStarted: November 21, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 32
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Healthy volunteers recruited from local optometrists
- •2. Male or female
- •3. Aged 50 or older
Exclusion Criteria
- •1. Type 1 and 2 diabetics
- •2. Pregnancy or intention to become pregnant
- •3. History of estrogen sensitive cancer
- •4. Warfarin users
- •5. Neovascular age-related macular degeneration (AMD) sufferers
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of AFL footballers.exercise performanceAlternative and Complementary Medicine - Other alternative and complementary medicineMusculoskeletal - Normal musculoskeletal and cartilage development and functionACTRN12622000435785a Trobe University40
Not yet recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of cyclists.ACTRN12622000517774a Trobe University20
Recruiting
Not Applicable
Investigating the effect of French bark extract, Pycnogenol, as a supplement to improve exercise performance in a population of CrossFitters.ACTRN12622000510741a Trobe University20
Completed
Not Applicable
Supplementation with alpha-tocopherol and ascorbic acid to non-alcoholic fatty liver disease’s statin therapy in meon-alcoholic fatty liver disease (NAFLD)TCTR20180425001Ss. Cyril and Methodius University in Skopje74
Recruiting
Not Applicable
Verification of the effects of supplements containing inulin on muscle strength, cognitive function and mucosal immunity in the elderlyHealthy adultsJPRN-UMIN000041780ser Life Science Co., Ltd.50